Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  American Journal of Physiology. Endocrinology and Metabolism

• Publication date

  1997-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajpendo.1997.273.4.E815PMID 9357813
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Number and ultrastructure of epithelial cells in crypts and villi along the streptozotocin-diabetic small intestine: a quantitative study on the effects of insulin and aldose reductase inhibition

  2004cited by this paper
• Biological determinants of intestinotrophic properties of GLP-2 in vivo.

  1997cited by this paper
• Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2.

  1997cited by this paper
• Role of prohormone convertases in the tissue-specific processing of proglucagon.

  1996cited by this paper
• Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

  1996cited by this paper
• Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: their use as markers of neuroendocrine differentiation.

  1995cited by this paper
• Polyamines and Intestinal Epithelial Hyperplasia in Streptozotocin-Diabetic Rats

  1993cited by this paper
• Gastrin and the growth of the gastrointestinal tract.

  1993cited by this paper
• Response of tGLP-1 to nutrients in humans

  1993cited by this paper
• Glucagon-like peptide-1, a new hormone of the entero-insular axis.

  1992cited by this paper
• Secretion of proglucagon-derived peptides in response to intestinal luminal nutrients.

  1991cited by this paper
• Tissue-specific differences in the levels of proglucagon-derived peptides in streptozotocin-induced diabetes.

  1989cited by this paper
• The role of insulin-like growth factor I in growth of diabetic rats.

  1989cited by this paper
• Mechanisms of adaptation in rat small intestine: regional differences in quantitative morphology during normal growth and experimental hypertrophy.

  1989cited by this paper
• Isolation and characterisation of GLP‐1 7–36 amide from rat intestine Elevated levels in diabetic rats

  1988cited by this paper
• Paradoxical organ-specific adaptations to streptozotocin diabetes mellitus in adult rats.

  1988cited by this paper
• Increased intestinal growth in the streptozotocin-diabetic rat occurs prior to changes in hormone secretion.

  1988cited by this paper
• Fetal rat intestinal cells in monolayer culture: a new in vitro system to study the glucagon-like immunoreactive peptides.

  1987cited by this paper
• Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing.

  1986cited by this paper
• Food intake and gastric emptying in rats with streptozotocin-induced diabetes.

  1984cited by this paper
• Gastrin and growth of the alimentary tract in the streptozotocin-diabetic rat.

  1982cited by this paper
• The hormonal pattern of intestinal adaptation. A major role for enteroglucagon.

  1982cited by this paper
• Compensatory postresectional hyperplasia and starvation atrophy in small bowel: dissociation from endogenous gastrin levels.

  1977cited by this paper
• Proliferation rate and transit time of mucosal cells in small intestine of the diabetic rat.

  1977cited by this paper
• Glucose, Insulin, Pancreatic Glucagon and Glucagon-like Immunoreactive Materials in the Plasma of Normal and Diabetic Children. Effect of the Initial Insulin Treatment*

  1975cited by this paper
• Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: An immunohistochemical and immunochemical study

  1975cited by this paper
• Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function 1

  1971cited by this paper
• Effects of diabetes on intestinal growth in the rat.

  1971cited by this paper
• Anatomic Adaptation of the Alimentary Tract of the Rat to the Hyperphagia of Chronic Alloxan-Diabetes

  1966cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Hyperglycemia alters the gene and protein expression of CDC42 in small and large intestine of Sprague-Dawley rats.

  2026cites this paper
• Differential Effects of Losartan and Finerenone on Diabetic Remodeling, Oxidative Stress and ACE Activity in the Gastrointestinal Tract of Streptozotocin-Induced Diabetic Rats

  2025cites this paper
• The Possible Involvement of Glucagon-like Peptide-2 in the Regulation of Food Intake through the Gut–Brain Axis

  2024cites this paper
• GLP-2 regulation of intestinal lipid handling

  2024cites this paper
• Release of Lipids Stored in the Intestine by Glucagon-Like Peptide-2 Involves a Gut-Brain Neural Pathway

  2023cites this paper
• Disrupted and elevated circadian secretion of glucagon-like peptide-1 in a murine model of type 2 diabetes.

  2022cites this paper
• A starch-rich treat affects enteroinsular responses in ponies.

  2022cites this paper
• Histomorphometry Changes and Decreased Reactivity to Angiotensin II in the Ileum and Colon of Streptozotocin-Induced Diabetic Rats

  2022cites this paper
• Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy

  2021cites this paper
• Intraintestinal and Parenteral Administration of an Insulin Analogue Leads to Comparable Activation of Signaling Downstream of the Insulin Receptor in the Small Intestine

  2020cites this paper
• Enteric cholinergic neuropathy in patients with diabetes: Non‐invasive assessment with positron emission tomography

  2020cites this paper
• Diabetes-induced mechanophysiological changes in the small intestine and colon

  2017cites this paper
• Effect of oleanolic acid on small intestine morphology and enzymes of glutamine metabolism in diabetic rats.

  2017cites this paper
• Arteriosclerosis, Thrombosis, and Vascular Biology.

  2017cites this paper
• Diabetic Phenotype in the Small Intestine of Zucker Diabetic Fatty Rats

  2016cites this paper
• Glucagon-Like Peptide 2 (GLP-2) Stimulates Postprandial Chylomicron Production and Postabsorptive Release of Intestinal Triglyceride Storage Pools via Induction of Nitric Oxide Signaling in Male Hamsters and Mice.

  2015cites this paper
• Advanced glycation end-product expression is upregulated in the gastrointestinal tract of type 2 diabetic rats.

  2015cites this paper
• Novel therapies for the management of short bowel syndrome in children

  2013cites this paper
• The Acute Regulation of Intestinal Chylomicron Secretion by Glucagon-like Peptides

  2012cites this paper
• Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide are neuroprotective on cultured and mast cell co-cultured rat myenteric neurons

  2012cites this paper
• New insights into how the intestine can regulate lipid homeostasis and impact vascular disease: frontiers for new pharmaceutical therapies to lower cardiovascular disease risk.

  2011cites this paper
• The Role of the GLP-2 Receptor in Intestinal and Islet Adaptation to Changes in Nutrient Availability

  2011influential citation
• Effect of Oral Insulin on Diabetes-Induced Intestinal Mucosal Growth in Rats

  2011cites this paper
• The Effect of Glucagon-like Peptide-2 on Insulin-like Growth Factor-1 in Murine Intestinal Subepithelial Myofibroblasts

  2010cites this paper
• The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes

  2010cites this paper
• Glucagon−like Peptide−1 and−2 Levels in Children with Diabetic Ketoacidosis

  2009cites this paper
• Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36.

  2009cites this paper
• Cell proliferation of the ileum intestinal mucosa of diabetic rats treated with ascorbic acid.

  2008cites this paper
• Why diabetes patients are more prone to the development of colon cancer?

  2008cites this paper
• Effects of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on intestinal function in streptozotocin-induced diabetic rats.

  2007cites this paper
• Bile salt and cholesterol metabolism in diabetes mellitus type 1

  2006cites this paper
• The role of polyamines in glucagon-like peptide-2 prevention of TPN-induced gut hypoplasia.

  2006cites this paper
• Intestinal Apical Protein Transport in Health and Disease

  2006cites this paper
• Glucagon-like Peptide-2.

  2006cites this paper
• Longitudinal mechanical tension induces growth in the small bowel of juvenile rats

  2005cites this paper
• Glucose Dependence of the Regulated Secretory Pathway in αTC1-6 Cells

  2005cites this paper
• Renal brush border membrane glucose transport : regulatory mechanisms and adaptation to diabetic hyperglycaemia.

  2004cites this paper
• Glucagon-like peptide-1 and glucagon-like peptide-2

  2004cites this paper
• Glucagon-like peptide-2 stimulates the proliferation of cultured rat astrocytes.

  2003cites this paper
• Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa.

  2003cites this paper
• Dual regulation of cell proliferation and survival via activation of glucagon-like peptide-2 receptor signaling.

  2003cites this paper
• Enteral and parenteral nutrition in the care of patients with short-bowel syndrome.

  2003cites this paper
• Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2.

  2003cites this paper
• Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.

  2003cites this paper
• Biomechanical and morphometric intestinal remodelling during experimental diabetes in rats

  2003cites this paper
• Factors Enhancing Intestinal Adaptation after Bowel Compensation

  2003cites this paper
• Symposium: Glucagon-Like Peptide 2: Function and Clinical Applications

  2003cites this paper
• Biological actions and therapeutic potential of the glucagon-like peptides.

  2002cites this paper
• Foxa3 (HNF-3gamma) binds to and activates the rat proglucagon gene promoter but is not essential for proglucagon gene expression.

  2002cites this paper
• Gut adaptation and the glucagon-like peptides

  2002cites this paper
• Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats.

  2002cites this paper
• Minireview: the glucagon-like peptides.

  2001influential citation
• Glucagon-like peptide 2.

  2001cites this paper
• Therapeutic potential of the intestinotropic hormone, glucagon-like peptide-2

  2001cites this paper
• Changes in serotonin levels and 5-HT receptor activity in duodenum of streptozotocin-diabetic rats.

  2001cites this paper
• Suppression of apoptosis is responsible for increased thickness of intestinal mucosa in streptozotocin-induced diabetic rats.

  2001cites this paper
• Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats.

  2001cites this paper
• Glucagon-like peptide-2 stimulates gut mucosal growth and immune response in burned rats.

  2001cites this paper
• Intestinal Growth Adaptation and Glucagon-like Peptide 2 in Rats with Ileal–Jejunal Transposition or Small Bowel Resection

  2001cites this paper
• Pharmacotherapy and growth factors in the treatment of short bowel syndrome.

  2001cites this paper
• Maintaining Gut Integrity During Parenteral Nutrition of Tumor-Bearing Rats: Effects of Glucagon-Like Peptide 2

  2000cites this paper
• Proglucagon messenger ribonucleic acid and intestinal glucose uptake are modulated by fermentable fiber and food intake in diabetic rats

  2000cites this paper
• Glucagonlike peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion.

  2000cites this paper
• Synthesis, secretion and biological actions of the glucagon‐like peptides

  2000cites this paper
• New frontiers in the biology of GLP-2.

  2000cites this paper
• CHANGES IN THE EXPRESSION OF SMALL INTESTINE EXTRACELLULAR MATRIX PROTEINS IN STREPTOZOTOCIN‐INDUCED DIABETIC RATS

  2000cites this paper
• Characterization of the endogenous receptor and structure/function relationship of glucagon-like peptide-2

  1999cites this paper
• Regulation der GLP-1 Sekretion intestinaler L-Zellen Vergleich der enteroendokrinen GLUTag Zellinie mit einer Primärkultur fötaler Rattendarmzellen (FRIC)

  1999cites this paper
• Early Gastrointestinal Regulatory Peptide Response to Intestinal Resection in the Rat Is Stimulated by Enteral Glutamine Supplementation

  1999cites this paper
• Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans.

  1999cites this paper
• Biologic properties and therapeutic potential of glucagon-like peptide-2.

  1999cites this paper
• Proinsulin stimulates growth of small intestinal crypt-like cells acting via specific receptors.

  1999cites this paper
• mRNA levels of dipeptidyl peptidase IV decrease during intestinal adaptation.

  1999cites this paper
• Glucagon-like Peptide 2.

  1999cites this paper
• Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre

  1999cites this paper
• The glucagon-like peptides.

  1999cites this paper
• Glucagon-Like Peptides

  1998cites this paper
• A biological function for glucagon-like peptide-2.

  1998cites this paper
• Syndrome-AC: non-insulin-dependent diabetes mellitus and the anabolic/catabolic paradox.

  1998cites this paper
• lucagon-Like Peptide-2 Increases Intestinal Lipid Absorption and hylomicron Production via CD 36

  year unknowncites this paper